Results 141 to 150 of about 10,258 (173)
Some of the next articles are maybe not open access.
Expression and clinical significance of NKG2A and HLA-E in advanced laryngeal carcinoma
Pathology - Research and PracticeThe purpose was to detected features of the expression levels of NKG2A and its ligand HLA-E, a new member of the immune checkpoints, in advanced laryngeal carcinoma and their clinicopathologic significance.We analyzed the expression levels of HLA-E and NKG2A in multiple types of tumors utilizing the Tumor Immune Estimation Resource (TIMER) database and
Meina, Wen +6 more
openaire +2 more sources
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer
Cancer Cell, 2022Monica Garcia-Barros +2 more
exaly
Blockade of CD94/NKG2A Prevents EAE
Clinical Immunology, 2010Jianmei Leavenworth +5 more
openaire +1 more source
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division
International Journal of Cancer, 2022Linda Borst +2 more
exaly
Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
Vaccines, 2022Salim I. Khakoo +2 more
exaly